2026³â 03¿ù 19ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

EH Group Joins H2MARINE Project to Develop Next Generation Maritime Fuel Cells

´º½ºÀÏÀÚ: 2024-03-07

NYON, SWITZERLAND -- EH Group is a proud member of H2MARINE, a co-funded initiative by the EU’s Clean Hydrogen Partnership and SERI (Switzerland). The project is committed to innovation in hydrogen technologies, focused on the development of next generation PEM fuel cell stacks for marine applications.

It entails the comprehensive process of designing, assembly, and testing of FC stacks, engineered to generate 250-300 kW of electrical power, and addressing the specific challenges of maritime applications. Based on its unique FC technology, EH Group will contribute its high power density stacks, further developed and optimised for marine use.

With an overall budget of over 9Mio EUR, across 42 months, the project represents a significant step forward in the pursuit of sustainable energy solutions for the maritime sector. The project consortium consists of 13 partners across Europe, including key R&D institutes like VTT, EPFL, ZSW, University of Freiburg, and companies such as Beyond Gravity, CluBE, CLEOS, DANA REINZ-DICHTUNGS-GmbH, Greenerity GmbH, PowerCell Sweden AB, and Thyssenkrupp Marine Systems.

“Our high power density fuel cell technology has been recognised in its use for maritime applications, and we are delighted to contribute to its further development in this project. ” says Mardit Matian, Founder of EH Group.

“The marine sector is facing increasing pressure to decarbonise, and EH Group is committed with its H2MARINE collaborators to accelerate FCs role in solving that challenge.” states Christopher Brandon, Co-Founder.



 Àüü´º½º¸ñ·ÏÀ¸·Î

Angelini Pharma and Quiver Bioscience Partner on Strategic Collaboration and Licensing to Advance Novel Genetic Epilepsy Therapeutics
1NCE and Netmore Combine Cellular and LoRaWAN Access to Deliver Global IoT Coverage
Organon Enters into Agreement to License MIUDELLA¢ç, Sebela Pharmaceuticals¡¯ Hormone-Free Intrauterine Device
Qualitative Shifts in DDoS Attack Sophistication, Infrastructure Capacity, and Threat Actor Capabilities
AMWC 2026: Galderma Unveils Leading Innovation With Comprehensive Portfolio and Future‑Focused Holistic Aesthetic Strategies
Canoga Perkins and Druid Deliver FRER-Enabled Resilience for Mission-Critical Private 5G Networks
Galderma Gains Triple Approval for New Restylane Syringe in EU, US, Canada, Cementing Leadership in Injectable Aesthetics

 

LG Electronics To Unveil Advanced Compressor Solutions Engineered for ...
Sisvel Website Now Available in Chinese and Japanese
YolTech Therapeutics Announces Positive Interim Data on YOLT-202 for t...
AOP Health on Rare Diseases: Information. Collaboration. Innovation
Thales sets a world first in quantum-safe security for 5G networks
Sia Accelerates Its Development with More Than 400 Agents on Its Agent...
Phase 3 Data Show ENTYVIO¢ç May Fill Treatment Gap in Pediatric Ulcera...

 


°øÁö»çÇ×
´º½ºÁö Áß¹®Ç¥±â´Â À½Â÷ Ç¥±â¹æ½Ä '纽ÞÙó¢ ´Ï¿ì½ÃÁö'
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬银öõ(ÜÄÒ¬ÜØ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..